Altered microvasculature in pancreatic islets from subjects with type 1 diabetes

PLoS One. 2022 Oct 31;17(10):e0276942. doi: 10.1371/journal.pone.0276942. eCollection 2022.

Abstract

Aims: The transcriptome of different dissociated pancreatic islet cells has been described in enzymatically isolated islets in both health and disease. However, the isolation, culturing, and dissociation procedures likely affect the transcriptome profiles, distorting the biological conclusions. The aim of the current study was to characterize the cells of the islets of Langerhans from subjects with and without type 1 diabetes in a way that reflects the in vivo situation to the highest possible extent.

Methods: Islets were excised using laser capture microdissection directly from frozen pancreatic tissue sections obtained from organ donors with (n = 7) and without (n = 8) type 1 diabetes. Transcriptome analysis of excised samples was performed using AmpliSeq. Consecutive pancreatic sections were used to estimate the proportion of beta-, alpha-, and delta cells using immunofluorescence and to examine the presence of CD31 positive endothelial regions using immunohistochemistry.

Results: The proportion of beta cells in islets from subjects with type 1 diabetes was reduced to 0% according to both the histological and transcriptome data, and several alterations in the transcriptome were derived from the loss of beta cells. In total, 473 differentially expressed genes were found in the islets from subjects with type 1 diabetes. Functional enrichment analysis showed that several of the most upregulated gene sets were related to vasculature and angiogenesis, and histologically, vascular density was increased in subjects with type 1 diabetes. Downregulated in type 1 diabetes islets was the gene set epithelial mesenchymal transition.

Conclusion: A number of transcriptional alterations are present in islets from subjects with type 1 diabetes. In particular, several gene sets related to vasculature and angiogenesis are upregulated and there is an increased vascular density, suggesting an altered microvasculature in islets from subjects with type 1 diabetes. By studying pancreatic islets extracted directly from snap-frozen pancreatic tissue, this study reflects the in vivo situation to a high degree and gives important insights into islet pathophysiology in type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 1* / genetics
  • Diabetes Mellitus, Type 1* / pathology
  • Humans
  • Insulin-Secreting Cells* / pathology
  • Islets of Langerhans* / pathology
  • Microvessels / pathology
  • Pancreas / pathology

Grants and funding

This study was supported by a junior grant to M.L. from Diabetes Wellness Sweden. The study was further supported by the Family Ernfors Foundation (O.K.), the Novo Nordisk Foundation (O.K.), the Magnus Bergvall foundation (M.L), the Åke Wiberg Foundation, the Tore Nilsson Foundation (M.L), the Swedish Diabetes Association (O.K.), Gillbergska Stiftelsen, Barndiabetesfonden (O.K., O.S., and M.L.), and the Swedish Medical Research Council (2019-01415) (O.K.). Human pancreatic biopsies and isolated islets were obtained from the Nordic Network for Clinical Islet Transplantation, supported by the Swedish national strategic research initiative Excellence of Diabetes Research in Sweden (EXODIAB), the Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust.